Method For The Diagnosis Of Neuromyelitis Optica

Document № Publication date Application №
20160054318 February 25, 2016 14/780617

The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.